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Objective: This study reports the initial clinical results and experience with the planning of branched stent grafts in
high-risk patients with thoracoabdominal aortic aneurysms (TAAAs).
Methods:High-risk patients with TAAAs were considered for this study. Based on evaluation with computed tomography
angiography (CTA), 21 custom-made branched stent grafts were designed for the selected patients. Two patients had
associated bilateral aneurysms of the common iliac arteries, so an iliac branched device was also used.
Results: Between August 2006 and April 2008, 23 patients (10 women, 13 men) were selected to undergo endovascular
TAAA repair. Mean age was 72 years old. Two patients were excluded after 1-mm-slice CTA analysis. Eleven patients have
underdone TAAA repair so far. The mean follow-up period at present is 8 months (range, 18 days-21 months). Overall
technical success was accomplished in all 11 patients. Two renal artery branches occluded. Operative times varied from 3
to 8 hours. Mean contrast volume was 193 mL (range, 48-420 mL). Eight patients required a stay of <4 days at the
intensive care unit. Three patients died. Two deaths were procedurally related: one patient died of myocardial infarction,
and the other had ischemic cerebellar stroke and died 3 months later of pulmonary sepsis. The third patient was
readmitted 3 days after hospital discharge and died of alcoholic pancreatitis. One man had permanent paraplegia. Two
women had transitory paraparesis. Striking hematologic and systemic inflammatory abnormalities were observed.
Conclusion: Increasing reports on stent graft technology indicate that this procedure might become a reality in the future
for endovascular treatment of complex aneurysms in all aortic segments. Branched stent grafts seem to be feasible and can
be offered as an effective alternative to most patients with TAAAs, especially for those who are currently excluded from
open surgical procedures. ( J Vasc Surg 2008;48:30S-36S.)Thoracoabdominal aortic aneurysm (TAAA) repair is
likely one of the most invasive and least frequently per-
formed procedures by vascular and cardiovascular sur-
geons. Although highly specialized medical centers have
reported 30-day, 2-year, and 5-year survival rates1 as good
as 91%, 70%, and 59%, respectively, with an operative
mortality of 8.2%2, these are not the results seen in most
institutions worldwide. Overall estimates from recently
published results3 suggest a 30-day mortality of 19% and a
1-year mortality as high as 31%.4
It should be noted, however, that, although open
surgical treatment of TAAAs may seem too aggressive
because it is associated with high morbidity and mortality
rates, the natural course of this disease is even worse. Of 94
patients with TAAA who did not undergo operative repair,
only 24%were alive after 2 years, and half of the deaths were
aneurysm related.1
These data are among the reasons why modern endo-
vascular techniques are used with increasing frequency to
develop a less invasive and entirely endovascular approach
for the treatment of TAAAs. The first branched modular
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30Sendograft system was envisioned in 2001.5 In this report
we describe our initial results and the insights we gai-
ned after experience with this exciting, evolving new
technology.
METHODS
Patients with TAAAs and associated severe comorbidi-
ties, with anticipated high risk for a regular open procedure,
were considered for endovascular repair. All patients had
TAAAs with diameters of 6 cm and none had associated
aortic dissection. Once the arterial anatomy was considered
suitable based on the analysis with computed tomography
angiography (CTA) with 1-mm slice thickness, patients
were asked to give informed consent to undergo the pro-
cedure, which had previously been approved by the hospital
ethics committee.
We evaluated the chest, abdomen, and pelvic CTA
using adjunct three-dimensional analysis with the OsiriX
freeware (OsiriX Foundation, Geneva, Switzerland), and a
custom-made graft was designed and submitted to the
planning team from Cook-Australia Inc (Brisbane, Austra-
lia) for fine adjustments according to their own CTA anal-
ysis and device production.
At the time of this report, we have planned 21 en-
dografts and have already implanted 11. Our further con-
siderations regarding graft design will be based on the
experience with these 21 planned grafts, and surgical out-
come will be reported for 11 patients.
Device planning and design. The implanted devices
are constructed using the AAA Zenith (Cook Medical Inc,
Bloomington, Ind) endograft platform comprising stain-
less steel Z stents and woven polyester fabric of the same
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is the presence of a reducing stent and side branches (Fig 1,
A and B). The reducing stent, which is located distally to
the sealing zone, converts the main body into a 16-mm,
18-mm. or 22-mm cuff-bearing segment. This diameter is
planned based on the aortic lumen so that it can accommo-
date both the main body and the bridging covered stents
between the graft side branches and the visceral vessels.
The diameter of the distal segment is adjusted to be
sealed either to the diameter of a previous graft in those
patients who have already undergone open or endovascular
infrarenal aneurysm repair or return to a diameter of 22
Fig 1. A, Branched stent graft with one free-flow stent, one
internal sealing stent, followed by reducing stents, from which
emerge the proximal side branch.B,Detail of the emergence of the
side branches from the main stent graft module. C, Iliac side
branch device.mm, which will serve as a standard diameter for the overlapof a distal 24-mm bifurcated endograft that is placed simul-
taneously. Depending on the proximal extent of the aneu-
rysm, additional Zenith TX-2 (Cook Medical Inc) en-
dografts may be used proximally.
Two patients in this series had associated large bilateral
aneurysms of the common iliac artery, so another branched
device (Zenith Iliac Bifurcated Graft, Cook-Australia;
Fig 1,C) was also used in one side, together with contralat-
eral internal iliac artery coil embolization, according to the
technique detailed elsewhere.6
The proximal sealing zone of the graft consists of one
or two sealing stents with or without an uncovered proxi-
mal stent. Proximal barbs are added to the first sealing stent
or to the uncovered stent. We have avoided these last stents
when the landing zone is tortuous because we believe that
their use tends to cause a type IA endoleak, as observed in
our experience in the thoracic and abdominal aorta. When-
ever possible, however, we prefer to use one sealing stent
and one uncovered free-flow stent because we want to be
able to cover the least extent of healthy aorta and yet create
a graft landing zone that allows for good proximal fixation.
This has a special relevance given the risk of spinal cord
ischemia in these patients.
The side branches have 10, 18, or 21 mm in overlap
length and are 6 or 8 mm in diameter (Fig 1, A). The
planning of these branches follows two basic coordinates,
namely, the distance from the graft edge and their respec-
tive clock position in the aorta at the point of emergence.
Fig 2 depicts the distribution of the endograft side branches
relative to their clock position in the 21 grafts planned so
far, adapted to a four-branch graft, present in 75% of the
patients in this small series.
This clock position distribution shows that although
Fig 2. Distribution of the side branches (SB) in the first 21 stent
grafts planned, relative to their clock position.the planning is made individually, a clear pattern existed
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cause these are the positions of the side branches and do not
necessarily reflect the usual position of the typical visceral
arteries found at the thoracoabdominal segment. For ex-
ample, in patients with both the celiac trunk and the
superior mesenteric artery (SMA) emerging at the same or
approximate clock position, we tend to spread the side
branches apart so that they are at least “1 hour” from one
another; we found this to facilitate arterial catheterization
during the procedure. Of the 21 grafts planned, 2 had 5
side branches (2main left renal arteries, each), 16 had 4 side
branches (celiac trunk, SMA, right and left renal arteries,
except 1 graft with branches intended for the celiac truck
and a hepatic artery and no right renal), 2 had 3 side
branches (1 occluded celiac truck and 1 absent right renal
artery), and 1 graft had 2 side branches (celiac trunk and
SMA) and 2 reinforced fenestrations (right and left renal
arteries).
The bridging between the graft side branches and each
of the targeted visceral arteries is accomplished with Flu-
ency covered stents (C. R. Bard Inc, Tempe, Ariz) with
diameters preoperatively planned by CTA to match both
the visceral vessel and the side branch diameter. Because
this stent model is prone to kinking when flexed, we deploy
a second bare, self-expanding nitinol Zilver Vascular stent
(Cook Inc) inside the covered stent, with the same diame-
ter or 1 mm larger for extra radial force at overlapping
points and 1 cm longer to create a smoother transition from
the covered stent into the visceral artery.
Surgical procedures. Patients are placed under gen-
eral anesthesia for all interventions, which are performed in
the surgical theater with C-arm subtraction (GE OEC
Medical Systems, Salt Lake City, Utah). To lower the risk of
spinal cord ischemia, a spinal catheter is placed in all pa-
tients, and cerebrospinal fluid (CSF) is drained to an exter-
nal closed CSF drainage system set to maintain pressure
10 mm Hg during the first postoperative 48 hours,
regardless of the presence or absence of neurologic symp-
toms. While in the intensive care unit (ICU), the patient’s
mean blood pressure is maintained at 90 mm Hg, urine
output is monitored, and echocardiography is done fre-
quently to assess left ventricular filling to optimize volume
replacement. Continuous small doses of norepinephrine
are used when needed to keep the pressure at goal level, as
long as volume replacement is considered optimal.
If a branched iliac graft has to be placed, this is per-
formed first in conjunction with contralateral internal iliac
artery embolization (Fig 3). In future cases, as procedure
times decrease, we maybe able to revascularize both inter-
nal iliac arteries with double iliac bifurcated devices; such
procedures are already routinely performed in patients with
bilateral iliac aneurysms, with or without infrarenal aortic
aneurysms. To obtain access in patients with 8 mm iliac
arteries, bilateral exposure of the common femoral artery
through 4-cm transversal inguinal incisions is performed.
Patients with an access vessel diameter of 8 mm undergo
implantation of a retroperitoneal 10-mm Dacron iliac
conduit.The main branched graft is positioned with the side
branches 1 to 2 cm above the target visceral vessels, as
planned during the device-planning CTA study. Great pre-
cision at this point is not required because the bridging step
can accommodate even a relatively large misdeployment
error of about 60°; we have observed this in one patient, yet
technical success to complete the procedure was achieved.
Distal aortouniiliac or bifurcated grafts are then added to
complete the system. Before the wires and delivery sheaths
are removed from the iliac arteries, an angiogram is per-
formed to confirm visceral perfusion through the side
branches.
We then repair the femoral arteries with polypropylene
sutures and proceed to the last step, which is the implanta-
tion of the bridging stents. This is accomplished through a
left axillary artery exposure, as proximal as possible in the
arm, to accommodate a 40-cm 12F sheath (Cook Medical)
to maintain a workstation in the descending aorta, followed
by a long 80-cm 10F Flexor sheath advanced distally into
the visceral segment.
Predischarge CTA is performed using 1-mm slices if the
serum creatinine concentration is within normal reference
ranges; otherwise we plan CTAs for 1, 6, and 12 months,
and yearly thereafter. Double antiagregant therapy with
clopidogrel (75 mg daily) and aspirin (200 mg daily) is
maintained for 3months, and then aspirin (200mg daily) is
Fig 3. A three-dimensional computed tomography angiography
reconstruction shows a thoracoabdominal stent graft with four
branches, in adjunct to left internal iliac artery revascularization
with iliac side branch device and contralateral embolization of
internal iliac artery.maintained for life.
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Between August 2006 and April 2008, 23 patients (10
women, 13men) with a mean age of 72 years (range, 68-79
years) were selected to undergo endovascular TAAA repair
with branched, modular, custom-made devices. All patients
were considered unfit for open procedures, mostly due to
age, chronic obstructive pulmonary disease (COPD), cor-
onary disease, or previous abdominal aortic surgery (iso-
lated or not). All patients had hypertension.
Two patients were excluded after 1-mm-slice CTA
analysis revealed extremely tortuous anatomy with no
appropriate proximal landing zone for the graft. In 21
patients, the graft was planned according to their indi-
vidual anatomy. During the wait for the devices to be
produced, one patient died from aneurysm rupture and
one patient underwent open surgery because of immi-
nent aneurysm rupture. TAAA repairs were done in 11
patients, and the remaining eight are scheduled for sur-
gery, depending on device production and availability.
The mean follow-up period at present is 8 months
(range, 18 days-21 months).
Technical success was accomplished in all 11 patients,
without conversion, type I or III endoleaks, or limb occlu-
sion. In conjunction with the repair of TAAA aneurysms,
two bilateral common iliac aneurysms were treated with
iliac branched devices at one side and embolization at the
contralateral side (Fig 3). Two patients had a planned
adjunctive iliac conduit implanted. One patient required
unplanned successful emergency iliac artery reconstruction
because of common iliac artery rupture during manipula-
tion of a 24F sheath in a calcified 8-mm vessel. Temporary
occlusion after the iliac artery rupture was obtained first
with a CODA balloon (Cook Medical). Four patients did
not need the distal graft because of appropriate anatomy (1
patient) or a previous AAA graft (3 patients).
Of the 43 target visceral arteries, two bridging stents
for the celiac trunk could not be deployed due to uniden-
tified chronic occlusion; these will be commented on later.
Embolization of side branches was necessary in these two
patients, without adverse outcomes. Two renal branches
occluded: one intraoperative occlusion was followed by a
fatal myocardial infarction (MI), and one other occlusion
was noted at the 6-month follow-up, although this pa-
tient’s serum creatinine and urine output remained within
normal reference ranges.
Operative times varied widely, from 3 to 8 hours,
depending on the need for iliac artery conduit implantation
or on difficulties in catheterizing the celiac trunk, which
required constantly longer times for bridging. The mean
volume of low osmolarity contrast used was 193 mL
(range, 48-420 mL). Eight patients required 4 days of
intensive care unit (ICU) stay. One patient with CSF
infection stayed at the ICU for 10 days. and another with a
cerebellar stroke stayed for 20 days.
Three patients died, and two of these deaths were
procedurally related. One patient sustained a massive myo-cardial infarction 1 hour after the procedure. The other
patient had an ischemic cerebellar stroke on the first post-
operative day and died 3 months later of pulmonary sepsis.
The ischemic stroke might have been related to operative
manipulation of the subclavian and, consequently, the ver-
tebral artery. The third patient was readmitted because of
abdominal pain 3 days after hospital discharge after an
uneventful 5-day recovery, including 2 days at the ICU.He
died 10 days later after emergency laparotomy that revealed
non-necrotizing pancreatitis. The patient had a medical
history of alcohol addiction, and during laparotomy, the
patency of all four branches was confirmed by the general
surgery team. The connection of this death to the proce-
dure has not been clearly determined, but clinical evidence
suggests no direct relationship.
To assess motor impairment to inferior limbs due to
spinal cord ischemia, we adopted the Tarlov scale: 0, no
movement; 1, slight movement; 2, sits with assistance; 3,
sits alone; 4, weak hop; and 5, normal hop. One man had
onset of a grade 3 lesion after the first 12 hours in the ICU,
attributed to prolonged uncorrected hypotension. Spinal
drainage was maintained48 hours in an attempt to revert
symptoms; but by day 4 a multisensitive gram-positive CSF
infection had developed, which was successfully treated
with regular antibiotics and removal of the catheter. Two
women had a transitory grade 4 lesion for 24 hours, one
on postoperative day 1 and the other on day 5, but hospital
discharge was not delayed. One patient with previous
COPD had a postoperative pneumonia that delayed hospi-
tal discharge, but intubation or readmission to the ICUwas
not required.
The striking hematologic and systemic inflammatory
abnormalities observed by Chuter et al7 in a similar series
of patients were also observed in this series, with a
notable drop in the platelet count, an increase in the
white cell count, and an increase in C-reactive protein
levels (Figs 4-7). The serum creatinine concentration oth-
erwise remained stable in all patients but one; this patient’s
creatinine levels were elevated preoperatively, but he has
Fig 4. Platelet count at the night before surgery (pre-op), on
admission to the intensive care unit (0), and on the following
postoperative days in the 11 patients (lines) who underwent
branched graft implantation.not yet required dialysis after 17 months of follow-up. The
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responded well to fasting, nasogastric drainage, intense
venous hydration, and regular prokinetic drugs within 5
Fig 5. Levels of C-reactive protein on the night before surgery
(pre-op), on admission to the intensive care unit (0) and on the
following postoperative days in the 11 patients (lines) who under-
went branched graft implantation.
Fig 6. Levels of serum creatinine on the night before surgery
(pre-op), on admission to the intensive care unit (0) and on the
following postoperative days in the 11 patients (lines) who under-
went branched graft implantation.
Fig 7. Leucocytes count on the previous night of surgery
(pre-op), on admission to the intensive care unit (0) and on the
following postoperative days in the 11 patients (lines) who under-
went branched graft implantation.days in three patients.DISCUSSION
The report of this series does not pretend to nor is it
capable of establishing that endovascular treatment with
branched endografts is the standard therapy for a TAAA.
We believe, however, after being involved with the process
of planning the stent grafts as well as performing the
interventions, that this is a useful option that already offers
an effective alternative to patients who are at high risk for
open procedures. One aspect not mentioned in most arti-
cles about TAAA is that once a patient is given the diagnosis
of an aneurysm (especially one that cannot be treated with
open surgery), a sudden change in lifestyle is usually ob-
served, with a significant decline in the quality of life as
patients become fearful of engaging in activities of daily life
such as walking up the stairs or driving a car. Doctors often
tell their patients that they have “a bomb in their belly,”
which causes anxiety and frustration in the patients and
their families. We observed a significant improvement in
the quality of life of patients and families after treatment.
Creating an appropriate access path for the graft is
sometimes difficult, because we are frequently faced with
highly calcified iliac arteries and because the delivering
systems for these grafts are usually large (diameters of 22F
and 24F). We adopted 8 mm as the lower limit for regular
inguinal common femoral/iliac access. For smaller vessels
or those with anticipated extreme calcification, we learned
how to save time and be minimally invasive by placing an
iliac conduit through a retroperitoneal iliac exposure. Usu-
ally this conduit can also be used as an adjunct bypass to
stenosed iliac arteries, as has also been well described
before.7
In one patient with previous infrarenal aortic endo-
vascular repair, a disconnection of the contralateral iliac
extension occurred during the passage of the branched
endograft. This was only demonstrated later on CTA
follow-up, and correction is currently scheduled after
postponement due to a postoperative increase in the
serum creatinine level 2.0 mg/dL (Fig 6).
The access required for the bridging step can also be
challenging. One patient had a previous left internal mam-
mary coronary artery bypass graft and we used transesoph-
ageal echocardiography to monitor cardiac signs of isch-
emia after placing a 12F sheath into the left subclavian
artery. Placing it into the right side was considered to have
a greater risk for cerebral embolization. Because the bra-
chial artery is usually thinner than expected, we regularly
perform the dissection of the third part of the axillary artery
at the portion where the humeral arteries are seen, while
special care is taken to protect the brachial plexus nerves
from trauma.
The CTA in two patients showed highly stenosed but
patent celiac trunks, and an intraoperative angiogram re-
vealed short occlusion of the artery. A possible reason for
this is because CTA does not reveal the flow direction as
does contrast angiography. In both patients we faced a
challenge to close the graft with the 8-mm side branches
intended for the celiac trunk, and the solution was to
becau
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sac and fill it with coils. Control CTA in both cases showed
no endoleak at 11 and 18 months, with no aneurysm
increase in diameter.
The mortality and surgical indications for TAAAs have
been classified into four types.2,8 However, aortic coverage
after open repair is generally different than after endovas-
cular repair. Endovascular repair of a type IV aneurysm
actually requires covering a proximal segment of healthy
aorta above the diaphragm, thereby simulating in fact a type
III repair; whereas a type I repair will require coverage of a
normal aorta below the aneurysm, with extension similar to
that of a type II repair. This might have future implications
in predicting blood and fibrinolytic changes, systemic in-
flammatory responses, and spinal cord ischemia, although
the real relationship between these has not yet been estab-
lished, despite some initial reports.9-11
We suggest that in the future these patients should be
classified according to the extent of the aortic coverage by
the endograft instead of the extent of diseased aorta. This
new classification will represent the real extent of endovas-
cular operative trauma. In this series we were unable to
correlate a decrease in platelet count, a rise in leukocyte
count, and inflammatory markers to the length of the graft
or to previous abnormalities in blood parameters as seen in
other reports,7,11 possibly because of the small number of
patients included in this study. For the same reason we did
not use a Kaplan-Meier survival curve to estimate survival;
however, a detailed table with patient characteristics is
Table. Patient complications
Patient Sex Age ASA
Major comorbididity
or surgery Pe
1 M 72 III 1. Ao surgery 1. Panc
2. MI 2. Deat
2 M 72 III 1. Stroke 1. Strok
2. GI cancer
3 M 68 III 1. MI 1. Rena
2. MI
3. Deat
4 F 75 III 1. HTS None
5 M 76 III 1. Ao surgery 1. Ileus
2. COPD 2. Parap
3. Spina
6 M 74 III 1. Ao surgery 1. Ileus
2. RI–n
7 M 79 III 1. MI None
8 M 68 III 1. COPD None
9 M 74 III 1. COPD 1. Pneu
2. Ileus
10 F 72 III 1. Ao surgery 1. Tran
11 F 72 III 1. MI 1. Tran
Total 72 3 Ao–3 COPD–4 MI 3 Ileus;
Ao, Aortic; COPD, chronic obstructive pulmonary disease; GI, gastrointesti
insufficiency.
aSide branches were deliberately embolized with coils during the procedureprovided (Table).The current system used for endovascular repair of
TAAA still has several deficiencies. Improvement in graft
flexibility and applicability can be expected once a specific
bridging stent is available to complete the system. Unfor-
tunately, the currently available covered stents have a ten-
dency to kink when flexed, lack conformability, and require
large diameter sheaths placed into the axillary and subcla-
vian arteries for delivery. The need for a second internal
stent also increases costs, operative time, and the risks of
complications. The availability of a standard device with
prefabricated branches to treat at least 80% to 90% of TAAA
aneurysms, as demonstrated in Fig 2, would eliminate the
long waiting time for custom-made devices for most pa-
tients.
An increasing number of reports on branched stent
graft technology indicate that this procedure might be-
come a reality in the future for endovascular treatment of
complex aneurysms in all aortic segments.7,9,11-20We share
this opinion, having found that the use of available custom-
made branched stent grafts is feasible and can be offered as
a safe, effective alternative for patients with TAAAs, espe-
cially for high risk patients with clinical comorbidities that
would preclude open surgical procedures.
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Dr JohnHarris (Sydney, Australia). On several of the examples
you showed us, the stent grafts were taken 3 to 4 cm into the visceral
vessels. Why have you placed them so far into those arteries?aneurysms, and we deployed the bridging stent way down into
these arteries. We actually do not have an established pattern for
that. It really depends on the procedure and how much overlap we
feel is needed for each artery.
